Anzeige
Mehr »
Montag, 15.09.2025 - Börsentäglich über 12.000 News
Jetzt investieren - "Neubewertung Extrem" durch Übernahme?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0JEGY | ISIN: AU000000CUV3 | Ticker-Symbol: UR9
Tradegate
12.09.25 | 21:43
5,955 Euro
-0,83 % -0,050
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
CLINUVEL PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
CLINUVEL PHARMACEUTICALS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
5,9656,08514.09.
5,9556,05012.09.

Aktuelle News zur CLINUVEL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.09.CLINUVEL PHARMACEUTICALS LIMITED: Chair's Letter to Shareholders61
04.09.Dividendenbekanntmachungen (04.09.2025)9.246 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADMIRAL GROUP PLC  GB00B02J6398  1,15 GBP  1,3255 EUR  AEGON LTD ADR  US0076CA1045  0,2206 USD  0,1891 EUR  AMCOR PLC CDIS  AU000000AMC4  0...
► Artikel lesen
03.09.CLINUVEL PHARMACEUTICALS LIMITED: Date of Annual General Meeting27
29.08.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL Annual Results - Investor Webinar67
28.08.Clinuvel Pharmaceuticals reports FY results63
28.08.CLINUVEL PHARMACEUTICALS LIMITED: Investor Presentation63
CLINUVEL Aktie jetzt für 0€ handeln
28.08.CLINUVEL PHARMACEUTICALS LIMITED: Appendix 4G21
28.08.CLINUVEL PHARMACEUTICALS LIMITED: Corporate Governance Statement11
28.08.CLINUVEL PHARMACEUTICALS LIMITED: Dividend/Distribution - CUV45
28.08.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL delivers ninth consecutive revenues growth & profit28
28.08.CLINUVEL PHARMACEUTICALS LIMITED: Appendix 4E and Annual Report to Shareholders 202526
22.08.Clinuvel Pharmaceuticals Limited: CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist401Executive summary plan to upgrade American Depository Receipt (ADR) program (CLVLY) to a Level II ADR listed on Nasdaq, expected before the end of 2025CLINUVEL's primary listing on the ASX will remain...
► Artikel lesen
22.08.Why Clinuvel, Cuscal, Electro Optic Systems, and Zip Co shares are storming higher today40
22.08.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL preparing upgrade of ADR program, NASDAQ uplist33
21.08.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL Annual Results - Investor Webinar41
07.08.CLINUVEL PHARMACEUTICALS LIMITED: Bioshares Biotech Summit presentation39
30.07.CLINUVEL PHARMACEUTICALS LIMITED: Presentation to BTIG Biotech Conference61
01.07.CLINUVEL PHARMACEUTICALS LIMITED: Notification of cessation of securities - CUV61
23.06.CLINUVEL PHARMACEUTICALS LIMITED: German Non-deal Roadshow Presentation46
23.06.Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH): Buy637Original-Research: CLINUVEL Pharmaceuticals - from Parmantier & Cie. GmbH 23.06.2025 / 12:41 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer is...
► Artikel lesen
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3